145 related articles for article (PubMed ID: 16886140)
1. [Inflammatory response after coronary angioplasty - mechanisms and significance].
Koziński M; Kubica J
Kardiol Pol; 2006 Jul; 64(7):771-4; author reply 775. PubMed ID: 16886140
[No Abstract] [Full Text] [Related]
2. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Aggarwal A
Am Heart J; 2006 May; 151(5):e3; author reply e4. PubMed ID: 16644304
[No Abstract] [Full Text] [Related]
3. Endothelial dysfunction and inflammation after percutaneous coronary intervention.
Blum A; Schneider DJ; Sobel BE; Dauerman HL
Am J Cardiol; 2004 Dec; 94(11):1420-3. PubMed ID: 15566916
[TBL] [Abstract][Full Text] [Related]
4. Is C-reactive protein a prognostic marker after angioplasty?
Tousoulis D; Papageorgiou N; Stefanadis C
Heart; 2009 Jun; 95(12):957-9. PubMed ID: 19478108
[No Abstract] [Full Text] [Related]
5. [Prevention of restenosis after coronary stenting, problem soon resolved].
Kivelä A; Hartikainen J
Duodecim; 2005; 121(11):1227-36. PubMed ID: 15999982
[No Abstract] [Full Text] [Related]
6. Percutaneous coronary intervention for left main coronary artery disease.
Gauthier N; Le May MR
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):213-20. PubMed ID: 17338666
[TBL] [Abstract][Full Text] [Related]
7. Relation of C-reactive protein to restenosis after coronary stent implantation and to restenosis after coronary atherectomy.
Kawamoto R; Hatakeyama K; Imamura T; Ishikawa T; Date H; Shibata Y; Takenaga M; Asada Y; Eto T
Am J Cardiol; 2004 Jul; 94(1):104-7. PubMed ID: 15219517
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
9. Another attempt to deal with restenosis.
Colombo A
Catheter Cardiovasc Interv; 2005 Apr; 64(4):419-20. PubMed ID: 15789392
[No Abstract] [Full Text] [Related]
10. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
[TBL] [Abstract][Full Text] [Related]
12. Severe neutropenia under clopidogrel treatment three weeks after coronary stenting.
Schäfer A; Eigenthaler M; Bauersachs J
Thromb Haemost; 2007 Feb; 97(2):317-8. PubMed ID: 17264964
[No Abstract] [Full Text] [Related]
13. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
Hitsumoto T; Takahashi M; Iizuka T; Shirai K
J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
[TBL] [Abstract][Full Text] [Related]
14. Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein.
Skowasch D; Jabs A; Andrié R; Lüderitz B; Bauriedel G
Heart; 2005 Apr; 91(4):535-6. PubMed ID: 15772225
[No Abstract] [Full Text] [Related]
15. Drug-eluting stents or drug-eluting conduits for multivessel disease?
Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
[No Abstract] [Full Text] [Related]
16. Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
Ruef J; Hofmann M; Störger H; Haase J
Cardiovasc Revasc Med; 2007; 8(3):170-4. PubMed ID: 17765646
[TBL] [Abstract][Full Text] [Related]
17. Thienopyridines, a safety net with holes in it.
Wenaweser P; Hess OM; Meier B
Catheter Cardiovasc Interv; 2003 Jul; 59(3):303-4. PubMed ID: 12822145
[No Abstract] [Full Text] [Related]
18. Drug-coated stents boost benefits of angioplasty. These tiny devices keep unclogged arteries open but don't prevent blockages from arising in other heart arteries.
Harv Heart Lett; 2004 Jan; 14(5):4. PubMed ID: 14734293
[No Abstract] [Full Text] [Related]
19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
